Phase IIb/III Trials
Accelerate clinical trials with scale and precision
Success in Phase IIb and III clinical trials requires more than global reach, therapeutic expertise and operational excellence; it demands innovation. IQVIA’s advanced AI and technology help you navigate regulatory complexity, optimize enrollment strategies and drive patient engagement. With a global footprint spanning 100 + countries and access to diverse patient populations, we deliver measurable outcomes: faster timelines, reduced risk, improved quality and greater efficiency — so you can bring life-changing therapies to market.

